SGLT-2 inhibitors for inhibiting the Progression of chronic Kidney Disease

被引：1
作者：
Heine, Gunnar Henrik [1 ]
机构：
[1] AGAPLESION MARKUS KRANKENHAUS, Med Klin 2, Wilhelm Epstein Str 4, D-60431 Frankfurt, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2020年 / 145卷 / 11期
关键词：
NEPHROPATHY; IRBESARTAN;
D O I：
10.1055/a-1163-7590
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：762 / 766
页数：5
相关论文
共 50 条
[41]   Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes [J].
DeFronzo, Ralph A. ;
Bakris, George L. .
DIABETES OBESITY & METABOLISM, 2022, 24 (07) :1197-1205
[42]   Impact of haemoglobin A1c trajectories on chronic kidney disease progression in type 2 diabetes [J].
Low, Serena ;
Zhang, Xiao ;
Wang, Jiexun ;
Yeoh, Lee Y. ;
Liu, Yan L. ;
Ang, Su F. ;
Subramaniam, Tavintharan ;
Sum, Chee F. ;
Lim, Su C. .
NEPHROLOGY, 2019, 24 (10) :1026-1032
[43]   The protective effects of SGLT-2 inhibitors, GLP-1 receptor agonists, and RAAS blockers against renal injury in patients with type 2 diabetes [J].
Kuang, Zengguang ;
Hou, Ningning ;
Kan, Chengxia ;
Han, Fang ;
Qiu, Hongyan ;
Sun, Xiaodong .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (03) :617-629
[44]   Kidney progression project (KiPP): Protocol for a longitudinal cohort study of progression in chronic kidney disease of unknown etiology in Sri Lanka [J].
Vlahos, Penny ;
Schensul, Stephen L. ;
Nanayakkara, Nishantha ;
Chandrajith, Rohana ;
Haider, Lalarukh ;
Anand, Shuchi ;
Silva, Kalinga Tudor ;
Schensul, Jean J. .
GLOBAL PUBLIC HEALTH, 2019, 14 (02) :214-226
[45]   Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways [J].
Yaribeygi, Habib ;
Butler, Alexandra E. ;
Atkin, Stephen L. ;
Katsiki, Niki ;
Sahebkar, Amirhossein .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (01) :223-230
[46]   Renal Protection and Safety of Sodium-glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease [J].
Zhou, Tianbiao ;
Yao, Kaijin ;
Xie, Yina ;
Lin, Yongda ;
Wang, Jiali ;
Chen, Xiutian .
CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (21) :1659-1670
[47]   Managing Chronic Kidney Disease in Type 2 Diabetes in Family Practice [J].
Scott, David ;
Davidson, Jaime A. .
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2011, 103 (9-10) :952-959
[48]   Network meta-analysis on the efficacy and safety of finerenone versus SGLT2 inhibitors on reducing new-onset of atrial fibrillation in patients with type 2 diabetes mellitus and chronic kidney disease [J].
Zhang, Yaofu ;
Wang, Junheng ;
Jiang, Li ;
Wang, Tongxin ;
Li, Zhuang ;
Fu, Xiaozhe ;
Huang, Weijun ;
Xiao, Yonghua ;
Wang, Shidong ;
Zhao, Jinxi .
DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01)
[49]   Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria [J].
Ovrehus, Marius A. ;
Zuerbig, Petra ;
Vikse, Bjorn E. ;
Hallan, Stein I. .
CLINICAL PROTEOMICS, 2015, 12
[50]   Ischemic diabetic retinopathy as a possible prognostic factor for chronic kidney disease progression [J].
Lee, W. J. ;
Sobrin, L. ;
Kang, M. H. ;
Seong, M. ;
Kim, Y. J. ;
Yi, J-H ;
Miller, J. W. ;
Cho, H. Y. .
EYE, 2014, 28 (09) :1119-1125
12345